VASERETIC Side Effects

6773950-9 | Cough
on Jun 15, 2010 Female patient from UNITED STATES , 40 years of age, weighting 213.0 lb, was diagnosed with hypertension and was treated with Vaseretic (View Usage). Patient experienced the following unwanted or unexpected effects: cough. Vaseretic dosage: 10/12.5mg Once Daily P.o..

6589424-4 | Ascites, Cardio-respiratory Arrest, Cerebral Disorder, Coma, Electrocardiogram Qt Prolonged, Escherichia Infection, Hepatomegaly, Hypertonia, Hypokalaemia
Patient was taking Vaseretic (View Usage). Patient had the following side effects: ascites, cardio-respiratory arrest, cerebral disorder, coma, electrocardiogram qt prolonged, escherichia infection, hepatomegaly, hypertonia, hypokalaemia on Jan 25, 2010 from FRANCE Additional patient health information: Male patient , 64 years of age, was diagnosed with ventricular tachyarrhythmia, glaucoma (What is glaucoma?), type 2 diabetes mellitus, hepatitis b (What is hepatitis b?) and. Vaseretic dosage: (df Oral). During the same period patient was treated with COSOPT ((1 Gtt Bid Ophthalmic)) (View Cosopt Review and Cosopt Label ), DIAMOX SRC ((0.5 Mg Bid Oral)) (View Diamox Src Review and Diamox Src Label ), GLUCOPHAGE ((1000 Mg Qd Oral)) (View Glucophage Review and Glucophage Label ), GLICLAZIDE ((2 Df Qd Oral)) (View Gliclazide Review and Gliclazide Label ), NEBIVOLOL HCL ((5 Mg Qd Oral)) (View Nebivolol Hcl Review and Nebivolol Hcl Label ), BARACLUDE ((1 Df Qd Oral)) (View Baraclude Review and Baraclude Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ). Patient was hospitalized.

6443948-9 | Blood Potassium Decreased, Diarrhoea, Disorientation, Dysarthria, Euphoric Mood, Gait Disturbance, Hyponatraemia, Nausea, Syncope
Adverse event was reported on Oct 29, 2009 by a Female patient taking Vaseretic (View Usage) (Dosage: (20-12.5 Mg Tablet, 1 Mg, Once Daily Oral)) . Location: SWITZERLAND , 59 years of age, After Vaseretic was administered, patient had the following side effects: blood potassium decreased, diarrhoea, disorientation, dysarthria, euphoric mood, gait disturbance, hyponatraemia, nausea (What is nausea?), syncope. During the same period patient was treated with FLUOXETINE HCL ((30 Mg Bid Oral)) (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ), REMERON ((15 Mg Qd Oral)) (View Remeron Review and Remeron Label ), ARTHROTEC ((df Oral)) (View Arthrotec Review and Arthrotec Label ), CO DAFALGAN (View Co-dafalgan Review and Co-dafalgan Label ), CONCOR (View Concor Review and Concor Label ), CALCIMAGON D3 (View Calcimagon-d3 Review and Calcimagon-d3 Label ), LACRYCON /02221601/ (View Lacrycon /02221601/ Review and Lacrycon /02221601/ Label ), VOLTAREN (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

6441130-2 | Abdominal Distension, Blood Pressure Increased, Chest Pain, Headache, Heart Rate Increased, Muscle Spasms, Myalgia, Vomiting
on Nov 13, 2009 Male patient from UNITED STATES , 55 years of age, weighting 170.0 lb, was diagnosed with hypertension and was treated with Vaseretic (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, blood pressure increased, chest pain (What is chest pain?), headache (What is headache?), heart rate increased, muscle spasms, myalgia, vomiting. Vaseretic dosage: 10mg Once Daily.


6321590-8 | Abdominal Pain, Diarrhoea, Hypoaesthesia, Nervousness, Product Substitution Issue, Rash
on Aug 20, 2009 Female patient from UNITED STATES , 56 years of age, weighting 212.0 lb, was diagnosed with hypertension, anxiety (What is anxiety?) and was treated with Vaseretic (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), diarrhoea, hypoaesthesia, nervousness, product substitution issue, rash (What is rash?). Vaseretic dosage: 10-25 Bid Po Brand Name- More Than 11y. During the same period patient was treated with ATIVAN (1mg Tid Po Brand Name-more Than 11yr) (View Ativan Review and Ativan Label ).

5886504-3 | Haemolytic Anaemia
Patient was taking Vaseretic (View Usage). After Vaseretic was administered, patient had the following side effects: haemolytic anaemia on Aug 04, 2008 from FRANCE Additional patient health information: Male patient , 67 years of age, was diagnosed with atrial flutter, anaemia, dyslipidaemia and. Vaseretic dosage: . During the same period patient was treated with EPOETIN BETA (View Epoetin Beta Review and Epoetin Beta Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

5841005-3 | Haemolytic Anaemia
Adverse event was reported on Aug 04, 2008 by a Male patient taking Vaseretic (View Usage) (Dosage: ) was diagnosed with atrial flutter, anaemia, dyslipidaemia and. Location: FRANCE , 67 years of age, Patient experienced the following unwanted or unexpected effects: haemolytic anaemia. During the same period patient was treated with EPOETIN BETA (View Epoetin Beta Review and Epoetin Beta Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), THALIDOMIDE (View Thalidomide Review and Thalidomide Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ). Patient was hospitalized.

5738487-4 | Blood Glucose Increased, Blood Pressure Increased, Cataract, Cystitis, Dizziness, Ear Infection, Joint Swelling, Oedema Peripheral
on Apr 24, 2008 Female patient from UNITED STATES , weighting 163.0 lb, was diagnosed with blood pressure (What is blood pressure?) and was treated with Vaseretic (View Usage). Patient had the following side effects: blood glucose increased, blood pressure increased, cataract (What is cataract?), cystitis, dizziness (What is dizziness?), ear infection (What is ear infection?), joint swelling, oedema peripheral. Vaseretic dosage: (1 Df Qd 10/25 Mg Tablet Oral). During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), PRANDIN /00882701/ (View Prandin /00882701/ Review and Prandin /00882701/ Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5674207-X | Blood Cholesterol Increased, Blood Creatinine Increased, Blood Triglycerides Increased, Blood Urea Increased, Cardiovascular Disorder, Headache, Hypertension, Low Density Lipoprotein Increased, Metabolic Disorder
on Mar 11, 2008 Male patient from , 56 years of age, was diagnosed with hypertension and was treated with Vaseretic (View Usage). After Vaseretic was administered, patient had the following side effects: blood cholesterol increased, blood creatinine increased, blood triglycerides increased, blood urea increased, cardiovascular disorder, headache (What is headache?), hypertension, low density lipoprotein increased, metabolic disorder (What is metabolic disorder?). Vaseretic dosage: Unk, Qd. During the same period patient was treated with NORVASC (5 Mg, Qd) (View Norvasc Review and Norvasc Label ), LIPITOR (20 Mg, Qd) (View Lipitor Review and Lipitor Label ), CRESTOR (20 Mg, Qd) (View Crestor Review and Crestor Label ), EZETROL (Unk, Qd) (View Ezetrol Review and Ezetrol Label ), CALCIUM CHANNEL BLOCKERS (View Calcium Channel Blockers Review and Calcium Channel Blockers Label ), DIOVAN (Unk, Qd) (View Diovan Review and Diovan Label ), DIURETICS (View Diuretics Review and Diuretics Label ), DIOVAN HCT (160/25 Mg) (View Diovan Hct Review and Diovan Hct Label ).

4622920-5 | Cardiac Murmur, Diarrhoea, Erythema, Haemodynamic Instability, Hypotension, Lung Crepitation, Non-cardiogenic Pulmonary Oedema, Respiratory Failure
Patient was taking Vaseretic (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac murmur, diarrhoea, erythema, haemodynamic instability, hypotension, lung crepitation, non-cardiogenic pulmonary oedema, respiratory failure on Mar 14, 2005 from Additional patient health information: Female patient , 46 years of age, was diagnosed with hypertension and. Vaseretic dosage: Po. During the same period patient was treated with HYDROCHLOROTHIAZIDE (Po) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), ENALAPRIL (ENALAPRIL MALEATE) (NR) (ENALAPRIL MALEAT) (20 Mg) (View Enalapril (enalapril Maleate) (nr) (enalapril Maleat) Review and Enalapril (enalapril Maleate) (nr) (enalapril Maleat) Label ). Patient was hospitalized.